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Breaking the symmetry: C1-salans with (N–H)
backbones†
Jack Devonport, John Spencer * and George E. Kostakis *
We disclose a synthetic route that providess an unprecedented
library of C1 salan ligands endowed with (N–H) backbones, pre-
viously limited to N-methylated backbones. Efforts to identify
a generic complexation protocol to yield the corresponding
Cu(II)–salan complexes demonstrate the scope and limitations of
this approach.
Salens, salans and salalens (Scheme 1) are metal chelators
derived from 2-hydroxybenzaldhydes (salicylaldehydes) and
1,2-diamines.1 They offer a tetradentate [ONNO] coordination
environment and bind to a wide range of transition metal
ions.2–9 The corresponding complexes have been extensively
researched for a wide range of applications ranging from cata-
lysis, sensors, biomimetics and medicinal bioinorganic
molecules.6–8,10–12 Salans have increased flexibility, thus yield-
ing complexes with less restricted coordination geometries.
Salens and their complexes tend to be susceptible to hydro-
lysis,13 which limits their use in applications that require
aqueous, acidic or basic media.14 Symmetric, C2-salen and
salan ligands account for the majority of the structures
studied thus far due to their ease of synthesis (Scheme 1, A
and B).1,6–8,10–12 Breaking of the C2-symmetry was deemed to
be a means to expand the repertoire of complexes for studies,
inter alia, in biomimetics, magnetism, sensing, catalysis. This
can be achieved by varying the salicylaldehyde derivative,
amine linker or via amine N-functionalisation (Scheme 1, C
and D).15 Although non-symmetric C1 ligands permit finer
control over electronic and steric properties, solubility studies
remain limited compared to similar symmetric structures. For
salens, C1-ligands have been developed using modular syn-
thetic strategies,16 but this approach is limited to scaffolds
containing 1,2-diaminocyclohexane or 1,2-phenylenediamine
backbones.16–18 Access to ethylene-based C1-salens can be
achieved via metal templated synthesis involving first, the for-
mation of a ‘half-unit’ Cu(II) complex, followed by conden-
sation of a second salicylaldehyde derivative.19 However, metal
templating limits significantly the scope of the ligands and
complexes that can be studied. C1-salan and salalens based on
the N,N′-dimethylethylenediamine backbone have been estab-
lished and their complexes investigated in catalysis.7,20–22
Synthesis of non-symmetric type ligands requires two steps;
mono-condensation of salicylaldehyde with a secondary
diamine followed by N-alkylation with a bromomethyl deriva-
tive (Scheme 1, C and D).23,24 Future investigations of C1-salan
ligands and complexes are greatly limited by the necessity for
a secondary amine backbone and both salicylaldehyde and
bromomethyl starting materials.
We recently reported that Cu(II) C2-salan and C2-salen based
complexes promote A3 coupling reactions in open air.25 In
order to expand this study, our first effort was to break the
symmetry and modify the ligand scaffold in the C2-salan com-
plexes. The simplest route towards Non-Symmetric C1-Salan
Ligands (NSSL) containing secondary diamine (N–H) back-
Scheme 1 Structure of salen/salan derived metal complexes discussed
in this work.
†Electronic supplementary information (ESI) available: 1H-NMR, 13C-NMR,
HRMS, FTIR, TG, IR, UV-Vis. CCDC 2086033–2086040. For ESI and crystallo-
graphic data in CIF or other electronic format see DOI: 10.1039/d1dt01950c
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bones is the reduction of the corresponding C1-salen
(Scheme 1, E). Surprisingly, no complexes derived from ethyl-
ene-based NSSLs have been deposited in the CCDC,26 and, to
the best of our knowledge, no ligands of this type have pre-
viously been reported. In this work, we present a two-step syn-
thetic method that yields C1-NSSLs bearing two distinct salicy-
laldehyde derivatives. The presented simple synthetic strategy
uses commercially available reagents, avoids, for the majority
of cases, column chromatographic purification and allows for
broad structural diversification.
Firstly, a salan ‘half-unit’ (Table 1) is prepared via the reduc-
tive amination of N-Boc-ethylenediamine and salicylaldehyde
followed by Boc-deprotection (Table 1). The salan ‘half-unit’
can be synthesised on a multigram scale in very good yield
(8.97 g, 78% over 2-steps). A second, different salicylaldehyde
unit can then be introduced (Table 1) to yield NSSLs. In almost
all cases, highly pure NSSLs precipitate as solids after quench-
ing the reduction mixture with water and allowing the aqueous
solution to stand overnight. Work-up and chromatography
were only required for NSSL-2, which was isolated as an oil.
NSSLs were isolated in moderate to good yields and character-
ised by 1H-NMR, 13C-NMR spectroscopy, HRMS and FTIR (see
ESI†). The provided table enlists only ten examples in which
R1 = R2 = H; however, the variations in the structure are almost
endless. R3 and R4 were chosen for study as these sites are
expected to impact complexation by altering pKa, inductive
effect, or coordination sphere (R3) and inducing electronic
effects (R4).
To further demonstrate the scope of the synthetic strategy,
Cyclohexane based Non-Symmetric Salans Ligands (CyNSSL)
were also synthesised starting from trans-N-Boc-1,2-cyclohexa-
nediamine. Related symmetric ligands have been investigated
as potential anti-cancer cytotoxic agents. Therefore, our
novel non-symmetric ligands greatly increases the scope of
possible structures accessible for anti-cancer research.27,28 A
range of CyNSS ligands were synthesised (Table 2) and charac-
terised with 1H-NMR, 13C-NMR, HRMS and FTIR (see ESI
Fig. S1–S53†).
After successfully expanding the family of NSSLs, we
attempted to develop a generic complexation protocol to
yield the corresponding M-NSS complexes. It is well known
that salan ligands can undergo metal-catalysed oxidative
dehydrogenation,29,30 and the rate of this process is metal
dependant; in organic solutions (Co(II) ≫ Ni(II) ≫ Cu(II)).29,31
We chose NSSL-1, NSSL-2 and NSSL-3, as they contain
bulky substituents at the R3 position to sterically crowd the
metal centre, as well as NSSL-4 and NSSL-5 that contain sub-
stituents at R4 that can induce further steric/electronic
effects.
The complexation reactions of the corresponding cyclo-
hexane (CyNSSL) analogues were also investigated. Bearing all
these in mind, we chose to study complexations with Cu(II)
ions to minimise the formation of oxidised derivatives. The
general complexation protocol can be summarised in three
steps; (1) heat-assisted complexation with CuCl2 in methanol
under aerobic conditions, (2) purification of the resultant com-
plexes with basified column chromatography to remove any
free ligand, (3) crystallisation of the compounds under aerobic
conditions, in various solvents followed by characterisation via
single crystal X-ray crystallography, where possible (see ESI†).
During complexation, all the solutions turned a deep green
colour upon the addition of CuCl2 other than for NSSL-3
(Table 3, entry 3), which turned to a dark brown colour and no
complex could be isolated. The purified compounds were then
characterised using CHN analysis, HRMS, FTIR, UV-Vis, TGA
(see ESI Fig. S54–S74†). The complexes showed similar absorp-
tion patterns in their UV-Vis spectra with an intense metal to
ligand charge transfer (MLCT) band at ∼380 nm and a broader
d-d transition band at ∼550 nm (Fig. S72†). Where possible,
thermogravimetric analysis was carried out to gain insight into
Table 1 Synthesis and structure of Non-Symmetric Salan Ligands
(NSSL)
R1 R2 R3 R4 Yield (%)
NSSL-1 –H –H –t-Bu –t-Bu 88
NSSL-2 –H –H –t-Bu –H 60
NSSL-3 –H –H –OMe H 73
NSSL-4 –H –H –H –OCF3 81
NSSL-5 –H –H –H –F 57
NSSL-6 –H –H –F –H 54
NSSL-7 –H –H –H –Br 51
NSSL-8 –H –H –Br –H 64
NSSL-9 –H –H –Me –H 45
NSSL-10 –H –H –H –OMe 60
Table 2 Synthesis and structure of Cyclohexane based Non-Symmetric
Salan Ligands (NSSL)
R1 R2 R3 R4 Yield (%)
CyNSSL-1 –H –H –t-Bu –t-Bu 68
CyNSSL-2 –H –H –t-Bu –H 50
CyNSSL-3 –H –H –OMe –H 62
CyNSSL-4 –H –H –H –OCF3 74
CyNSSL-5 –H –H –H –F 74
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the thermal stability of the formed complexes. Complexes
derived from sterically bis-substituted bulky ligands (Table 3,
entries 1 & 6) began to degrade at ∼100 °C. In contrast, all the
other studied complexes were stable up to 175–250 °C (Fig. S73
and S74†). The general notion is that the complexes formed
from CyNSSLs are more thermally stable. The formation of
CvN bonds, via oxidative dehydrogenation was observed
when complexing ligands with tert-butyl substituents close to
the coordination cage (Table 3; entries 1, 2, 6 & 7). The for-
mation of the CvN bonds was evidenced in their HRMS
(Fig. S63, S64, S67 and S68†) and by a characteristic strong
absorption at ∼1650 cm−1 in their FTIR spectra (Fig. S54,
S55, S58 and S59†). This observation may suggest that
more sterically crowded ligands undergo oxidative dehydro-
genation more readily then their less sterically encumbered
counterparts.
To further expand the scope and limitations of this generic
complexation protocol, we chose only two ligands (NSS-1 and
CyNSS-1) to investigate their complexation behaviour under
anaerobic conditions with CuCl2. In both cases, we observed
the Cu–salan product as the major product. This observation
could be evidenced by IR (Fig. S75†) and the absence of the
characteristic CvN band at 1600 cm−1 and HRMS. The latter
studies showed a molecular ion peak with an isotopic distri-
bution corresponding to the salan product (+2 compared to
the original (see Fig. S76 & 77†). Notably, the HRMS of Cu-
NSS-1 shows additional small peaks corresponding to the Cu–
salen complex indicating that sample Cu-NSS-1 is subject to
partial dehydrogenation upon exposure to O2 or during the
column conditions. This process could be further corroborated
by the presence of a small peak in the IR at 1640 cm−1 corres-
ponding to the CvN bond (Fig. S75†). The dehydrogenated
product is not observed in the HRMS or FTIR of the Cu-
CyNSS-1 sample, but the yield of the complexation is signifi-
cantly lower.
X-ray quality crystals for the copper complexes were grown
by suspending either the column purified complexes (Table 3,
entries 1, 6, 8, 9 & 10) or crude, pre-column, material (Table 3,
entries 2, 3 & 7), in various organic solvents and allowing the
solutions to evaporate at ambient temperature under aerobic
conditions. Crystallisation experiments were unsuccessful for
only two cases (Table 3, entries 4 & 5), while for entry 2, low
quality crystallographic data, not provided herein, suggest
possible dehydrogenation (see ESI†).
Crystallographic studies reveals that in the solid-state, Cu–
salan complexes (Table 3, entries 3, 8, 9, 10 & 11), Cu–salalen
complexes (Table 3, entries 1 & 7) and Cu–salen complexes
(Table 3, entry 6) are formed as a result of oxidative dehydro-
genation (Fig. 1). This oxidative process is solely observed for
complexes derived from sterically hindered ligands with tert-
butyl substituents. Interestingly, crystallisation of the purified
product obtained when complexing CyNSS-1 resulted in both
salalen (Table 3, entry 7) and salen (Table 3, entry 6) complexes
depending on the crystallisation solvent. Therefore, metal salt,
ligand structure and solvent all can affect the oxidative dehy-
drogenation of salan-metal complexes. Future complexation
procedures should be specifically tailored to the ligand used,
and the desired complex and all of these parameters should be
taken into account.
In the solid state, the Cu(II) complexes were observed to
form either monomeric species (Table 3, entries 3, 6, 7, 8 & 9)
or dimer species (Table 3, entries 1, 10 & 11). The monomeric
species result from a planar arrangement of the nitrogen
atoms and oxygen atoms of the ligand complexing to the
central Cu(II) ion. The presence of apical solvent molecules
results in a 5-cooriniate trigonal pyramidal geometry and can
alter the stereochemistry around the amine nitrogen atoms
(Table 3, entry 3). Two types of dimeric structure were observed
with bridging occurring via the presence of chlorides ions
(Table 3, entry 1) or direct coordination of a second Cu(II) via a
phenoxide moiety (Table 3, entries 10 & 11). Complexation of
NSS-1 resulted in an asymmetric dimer, bridged by two chlor-
ides where one phenol unit remains protonated, forming a
6,5-fused ring system. HRMS data suggest that, in solution,
this species is broken down (Fig. S63†). Complexes obtained
from the cyclohexene-based ligands that contain electron-with-




Entry Ligand Yielda (%) –CvN bond(s)b Crystallised species Solid-state structuree Coordination environment
1 NSSL-1 83 Y Salalenc {Cu2L′2Cl2} N2OCl2
2 NSSL-2 41 Y N.R N.R
3 NSSL-3 N.R N.R Saland [CuL(H2O)] N2O3
4 NSSL-4 94 N N.R N.R
5 NSSL-5 79 N N.R N.R
6 CyNSSL-1 83 Y Salenc [CuL″] N2O2
7 CyNSSL-1EtOAc — — Salalen [CuL′] N2O2
8 CyNSSL-2 12 Y Saland [CuL] N2O2
9 CyNSSL-3 56 N Salanc {[CuL(H2O)0.5][CuL]} 3(H2O) (CH3OH) N2O3 & N2O2
10 CyNSSL-4 83 N Salanc [Cu2L2] N2O3
11 CyNSSL-5 38 N Salanc {[CuL][Cu2L2]} 2(MeOH) N2O2 & N2O3
N.R = No Result. a Yield of product isolated after column chromatography. b Presence of characteristic imine (CvN) bond in FTIR and HRMS.
c Crystallised from purified post-column product. dCrystallised from pre-column crude product. e L = salan ligand, L′ = salalen ligand, L″ = salen
ligand.
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drawing groups, CyNSS-4 and CyNSS-5, revealed the formation
of a dimeric stacked couples (Table 3, entries 9 & 10). In the
stacked couples the electron deficient ring is stacked above the
electron richer, unsubstituted ring, (R1 = R2 = H). Suitable crys-
tals for the similar ethylene analogues could not be obtained
despite our best efforts.
We have previously shown that C2-Cu(II)–salen and Cu(II)–
salan complexes enable the A3 coupling transformation at
room temperature in open air without the need for any addi-
tives.25 Spurred by the success of these efforts, the catalytic
activity of the non-symmetric complexes in the synthesis of a
simple propargylamine was investigated. Under the given
experimental conditions (see ESI†), the Cu(II) complexes per-
formed moderately with 1H-NMR conversions ranging from
27–55% (Table S15†). However, variation in the catalytic
results exemplifies how future catalytic activity can be tuned
by variation in the ligand structure. Despite poor catalytic
results, the increased tunability now possible for CyNSSLs
offers an opportunity to better understand the structure–
activity relationship (SAR) relating to their use as anti-cancer
agents.27,28 Potentially leading to the identification of new
therapeutic candidates.
To conclude, we have characterised 15 examples of C1-
salans with N–H backbones and investigated the use of ten of
them to yield the corresponding Cu(II) complexes via a generic
synthetic protocol. From the data above, it is evident that in
the solid-state, the structure of the crystallised material
depends on many factors. The complexation of NSSLs with
metal ions cannot be generalised and instead seems to be
reliant on the ligand being used and the desired complex.
Further development of NSS-complexes may require complexa-
tion and crystallisation to take place under anaerobic con-
ditions to avoid oxidative dehydrogenation. It can also be envi-
saged that adaptation of the complexation procedure could
exploit the oxidative dehydrogenation process for the synthesis
of novel C1-salen and salalen metal complexes. The possible
variations in the ligand and complex framework with this
approach are almost endless. A popular chemical vendor offers
100 different salicylaldehyde derivatives; thus, the adaptation
of our protocol could allow for the synthesis of 4950 NSSLs
from a single diamine backbone. Further variation in the
metal centre or diamine backbone used would enable access
to a huge array of NSS-complexes. Salan ligands and corres-
ponding metal complexes are already used in a wide range of
applications; therefore, our synthetic strategy will have mani-
fold potential applications ranging from coordination chem-
istry, magnetism, sensing, catalysis to biology and biomedical
investigations.
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Fig. 1 Solid-state structures of Cu(II) complexes summarised in Table 3. Colour coding Cu (blue), C (grey), O (red), N (light blue), Cl/F (green), H
(white). In some compounds H-atoms are omitted for clarity.
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